UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 69

Sortiert nach

HI extraction by H3PO4 in the Sulfur-Iodine thermochemical water splitting cycle: Composition optimization of the HI/H2O/ H3PO4/I2 biphasic quaternary system

International journal of hydrogen energy, 2009-08, Vol.34 (15), p.6120-6128

2009

Volltextzugriff (PDF)

HI extraction by H sub(3PO) sub(4) in the Sulfur-Iodine thermochemical water splitting cycle: Composition optimization of the HI/H sub(2O/H) sub(3)PO sub(4/I) sub(2) biphasic quaternary system

International journal of hydrogen energy, 2009-08, Vol.34 (15), p.6120-6128

2009

Volltextzugriff (PDF)

HI extraction by H 3PO 4 in the Sulfur–Iodine thermochemical water splitting cycle: Composition optimization of the HI/H 2O/H 3PO 4/I 2 biphasic quaternary system

International journal of hydrogen energy, 2009, Vol.34 (15), p.6120-6128

2009

Volltextzugriff (PDF)

Long-Term Outcomes of Intravenous Ustekinumab Maintenance Treatment in Patients With Loss of Response to Subcutaneous Dosing

Inflammatory bowel diseases, 2024-07

2024

Volltextzugriff (PDF)

Effectiveness and Safety of CT-P13 (Biosimilar Infliximab) in Patients with Inflammatory Bowel Disease in Real Life at 6 Months

Digestive diseases and sciences, 2017-05, Vol.62 (5), p.1305-1312

2017

Volltextzugriff (PDF)

Prevalence and Factors Associated With Fatigue in Patients With Inflammatory Bowel Disease: A Multicentre Study

Journal of Crohn's and colitis, 2019-08, Vol.13 (8), p.996-1002

2019

Volltextzugriff (PDF)

A new digital health tool for the telemonitoring of patients with scleroderma during iloprost administration: a feasibility and acceptability study

European review for medical and pharmacological sciences, 2023-01, Vol.27 (2), p.799

2023

Volltextzugriff (PDF)

Mo1836 RESULTS AT 52 WEEKS OF INTRAVENOUS USTEKINUMAB MAINTENANCE TREATMENT IN PATIENTS WITH LOSS OF RESPONSE TO SUBCUTANEOUS DOSES: A MULTICENTER OBSERVATIONAL RETROSPECTIVE STUDY

Gastroenterology (New York, N.Y. 1943), 2024-05, Vol.166 (5), p.S-1135-S-1136

2024

Volltextzugriff (PDF)

P690 Monitoring ustekinumab levels in Inflammatory Bowel Disease in clinical practice: a window of opportunity

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i1309-i1310

2024

Volltextzugriff (PDF)

Does the Antitumor Necrosis Factor-α Therapy Decrease the Vertebral Fractures Occurrence in Inflammatory Bowel Disease?

Journal of clinical densitometry, 2019-04, Vol.22 (2), p.195-202

2019

Volltextzugriff (PDF)

P081 Therapeutic Drug Monitoring of infliximab in Crohn’s Disease: Cut-off points during maintenance therapy

Journal of Crohn's and colitis, 2022-01, Vol.16 (Supplement_1), p.i181-i182

2022

Volltextzugriff (PDF)

Systematic review of the literature and a case report informing biopsy-proven giant cell arteritis (GCA) with normal C-reactive protein

Clinical rheumatology, 2012-09, Vol.31 (9), p.1389-1393

2012

Volltextzugriff (PDF)

Characteristics and Treatment of Pyoderma Gangrenosum in Inflammatory Bowel Disease

Digestive diseases and sciences, 2013-10, Vol.58 (10), p.2949-2954

2013

Volltextzugriff (PDF)

Erratum to: Effectiveness and Safety of CT-P13 (Biosimilar Infliximab) in Patients with Inflammatory Bowel Disease in Real Life at 6 Months

Digestive diseases and sciences, 2017-08, Vol.62 (8), p.2203-2203

2017

Volltextzugriff (PDF)

P740 Results at 52 weeks of Intravenous Ustekinumab as Maintenance Treatment in Patients with Loss of Response to Subcutaneous Doses: A Multicenter Retrospective Observational Study

Journal of Crohn's and colitis, 2024-01, Vol.18 (Supplement_1), p.i1385-i1387

2024

Volltextzugriff (PDF)

Incidence, causative factors and mortality rates of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in northern Italy: data from the REACT registry

Pharmacoepidemiology and drug safety, 2016-02, Vol.25 (2), p.196-203

2016

Volltextzugriff (PDF)

Improvement of toughness properties of polypropylene/wollastonite composites using an interface modifier

Polymer composites, 2014-06, Vol.35 (6), p.1184-1192

2014

Volltextzugriff (PDF)

Developing regional locational guidance for wave and tidal energy in the Shetland Islands

Marine policy, 2014-12, Vol.50, p.53-66

2014

Volltextzugriff (PDF)

Switch From Twice-daily Tacrolimus to Once-daily, Prolonged-release Tacrolimus in Kidney Transplantation: Long-term Outcome

Transplantation proceedings, 2019-01, Vol.51 (1), p.140-142

2019

Volltextzugriff (PDF)

P187 Clinical follow-up of patients with Crohn's disease treated with ustekinumab in our hospital

Journal of Crohn's and colitis, 2019-01, Vol.13 (Supplement_1), p.S187-S188

2019

Volltextzugriff (PDF)

Effects of releasing two Diachasmimorpha longicaudata population lines for the control of Ceratitis capitata infesting three key host fruit species

Biological control, 2019-06, Vol.133, p.58-65

2019

Volltextzugriff (PDF)

Beta phase in polypropylene induced by shear in a single-screw extruder

Polymer engineering and science, 2012-08, Vol.52 (8), p.1672-1677

2012

Volltextzugriff (PDF)

Detection of antipituitary and antihypothalamus antibodies to investigate the role of pituitary or hypothalamic autoimmunity in patients with selective idiopathic hypopituitarism

Clinical endocrinology (Oxford), 2011-09, Vol.75 (3), p.361-366

2011

Volltextzugriff (PDF)

P335 Long-term follow-up of switching from original infliximab to infliximab biosimilar: real-world data

Journal of Crohn's and colitis, 2019-01, Vol.13 (Supplement_1), p.S268-S269

2019

Volltextzugriff (PDF)

Proton pump inhibitors in rheumatic diseases: clinical practice, drug interactions, bone fractures and risk of infections

Reumatismo, 2011-03, Vol.63 (1), p.5-10

2011

Volltextzugriff (PDF)

1 – 25 von 69

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(64)
Mit Volltextzugriff
(64)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(36)
Life Sciences & Biomedicine
(29)
Humans
(28)
Female
(21)
Adult
(15)
Male
(15)
Middle Aged
(14)
Surgery
(12)
Biological And Medical Sciences
(10)
Immunology
(10)
Medical Sciences
(10)
Transplantation
(10)
Aged
(8)
Gastroenterology & Hepatology
(7)
Retrospective Studies
(6)
Surgery . Transplantations, Organ And Tissue Grafts. Graft Diseases
(6)
Technology
(6)
Applied Sciences
(4)
Exact Sciences And Technology
(4)
Immunosuppressive Agents - Therapeutic Use
(4)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

HI extraction by H3PO4 in the Sulfur-Iodine thermochemical water splitting cycle: Composition optimization of the HI/H2O/ H3PO4/I2 biphasic quaternary system

HI extraction by H sub(3PO) sub(4) in the Sulfur-Iodine thermochemical water splitting cycle: Composition optimization of the HI/H sub(2O/H) sub(3)PO sub(4/I) sub(2) biphasic quaternary system

HI extraction by H 3PO 4 in the Sulfur–Iodine thermochemical water splitting cycle: Composition optimization of the HI/H 2O/H 3PO 4/I 2 biphasic quaternary system

Long-Term Outcomes of Intravenous Ustekinumab Maintenance Treatment in Patients With Loss of Response to Subcutaneous Dosing

Effectiveness and Safety of CT-P13 (Biosimilar Infliximab) in Patients with Inflammatory Bowel Disease in Real Life at 6 Months

Prevalence and Factors Associated With Fatigue in Patients With Inflammatory Bowel Disease: A Multicentre Study

A new digital health tool for the telemonitoring of patients with scleroderma during iloprost administration: a feasibility and acceptability study

Mo1836 RESULTS AT 52 WEEKS OF INTRAVENOUS USTEKINUMAB MAINTENANCE TREATMENT IN PATIENTS WITH LOSS OF RESPONSE TO SUBCUTANEOUS DOSES: A MULTICENTER OBSERVATIONAL RETROSPECTIVE STUDY

P690 Monitoring ustekinumab levels in Inflammatory Bowel Disease in clinical practice: a window of opportunity

Does the Antitumor Necrosis Factor-α Therapy Decrease the Vertebral Fractures Occurrence in Inflammatory Bowel Disease?

P081 Therapeutic Drug Monitoring of infliximab in Crohn’s Disease: Cut-off points during maintenance therapy

Systematic review of the literature and a case report informing biopsy-proven giant cell arteritis (GCA) with normal C-reactive protein

Characteristics and Treatment of Pyoderma Gangrenosum in Inflammatory Bowel Disease

Erratum to: Effectiveness and Safety of CT-P13 (Biosimilar Infliximab) in Patients with Inflammatory Bowel Disease in Real Life at 6 Months

P740 Results at 52 weeks of Intravenous Ustekinumab as Maintenance Treatment in Patients with Loss of Response to Subcutaneous Doses: A Multicenter Retrospective Observational Study

Incidence, causative factors and mortality rates of Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) in northern Italy: data from the REACT registry

Improvement of toughness properties of polypropylene/wollastonite composites using an interface modifier

Developing regional locational guidance for wave and tidal energy in the Shetland Islands

Switch From Twice-daily Tacrolimus to Once-daily, Prolonged-release Tacrolimus in Kidney Transplantation: Long-term Outcome

P187 Clinical follow-up of patients with Crohn's disease treated with ustekinumab in our hospital

Effects of releasing two Diachasmimorpha longicaudata population lines for the control of Ceratitis capitata infesting three key host fruit species

Beta phase in polypropylene induced by shear in a single-screw extruder

Detection of antipituitary and antihypothalamus antibodies to investigate the role of pituitary or hypothalamic autoimmunity in patients with selective idiopathic hypopituitarism

P335 Long-term follow-up of switching from original infliximab to infliximab biosimilar: real-world data

Proton pump inhibitors in rheumatic diseases: clinical practice, drug interactions, bone fractures and risk of infections

Suchergebnisse filtern